Skip to main content

Table 5 Antibiotic use in neonates (initial and overall) within 3 days of life

From: Early-onset neonatal sepsis and antibiotic use in Indonesia: a descriptive, cross-sectional study

Antibiotics

EOS

Non-EOS

(n = 797)

Culture proven

(n = 83)

Culture negative

(n = 112)

Absence of culture facility

(n = 47)

Initial antibiotics

 Ampicillin / Amoxicillin

76 (91.6%)

47 (42.0%)

3 (6.4%)

156 (19.6%)

 Gentamicin

17 (20.5%)

55 (49.1%)

10 (21.3%)

457 (57.3%)

 Amikacin

78 (94.0%)

73 (65.2%)

2 (4.3%)

229 (28.7%)

 Third-generation cephalosporin

27 (32.5%)

26 (23.2%)

41 (87.2%)

181 (22.7%)

Overall antibiotics

 Ampicillin / Amoxicillin

76 (91.6%)

48 (42.9%)

3 (6.4%)

157 (19.7%)

 Penicillin

0 (0.0%)

0 (0.0%)

0 (0.0%)

1 (0.1%)

 Gentamicin

19 (22.9%)

55 (49.1%)

10 (21.3%)

458 (57.5%)

 Netilmicin

39 (47.0%)

8 (7.1%)

0 (0.0%)

12 (1.5%)

 Amikacin

82 (98.8%)

74 (66.1%)

2 (4.3%)

229 (28.7%)

 Ampicillin-Sulbactam

1 (1.2%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

 Amoxicillin-Clavulanic acid

3 (3.6%)

45 (40.2%)

0 (0.0%)

398 (49.9%)

 Piperacillin-tazobactam

3 (3.6%)

28 (25%)

0 (0.0%)

93 (11.4%)

 Imipenem

4 (4.8%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

 Meropenem

20 (24.1%)

9 (8.0%)

0 (0.0%)

16 (2.0%)

 Doripenem

0 (0.0%)

0 (0.0%)

0 (0.0%)

3 (0.4%)

 Third-generation cephalosporin

68 (81.9%)

28 (25.0%)

41 (87.2%)

182 (22.8%)

 Fourth-generation cephalosporin

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (0.3%)

 Ciprofloxacin

0 (0.0%)

0 (0.0%)

0 (0.0%)

1 (0.1%)

 Vancomycin

1 (1.2%)

0 (0.0%)

3 (6.4%)

3 (0.4%)

 Metronidazole

11 (13.3%)

5 (4.5%)

0 (0.0%)

15 (1.9%)